A Phase II Trial of Intratumoral Injection with a Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and Neck

2003 ◽  
pp. 559-574 ◽  
Author(s):  
David H. Kirn
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Trial ◽  
Intratumoral Injection

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

Oncology ◽  
2000 ◽  
Vol 60 (1) ◽  
pp. 66-71 ◽  
Author(s):  
X. Pivot ◽  
L. Cals ◽  
D. Cupissol ◽  
E. Guardiola ◽  
X. Tchiknavorian ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Trial ◽  
Recurrent Squamous Cell Carcinoma

P2.90. A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck

2009 ◽  
Vol 3 (1) ◽  
pp. 190
Author(s):  
R.S. Weber ◽  
B.S. Glisson ◽  
S.A. Taylor ◽  
E.Y. Hanna ◽  
A.K. El-Naggar ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Trial ◽  
Cutaneous Squamous Cell Carcinoma

scholarly journals Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

2005 ◽  
Vol 11 (23) ◽  
pp. 8418-8424 ◽  
Author(s):  
Ezra E.W. Cohen ◽  
Madeleine A. Kane ◽  
Marcy A. List ◽  
Bruce E. Brockstein ◽  
Bhoomi Mehrotra ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Trial ◽  
Metastatic Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document